SIG
AMGN icon

Stanford Investment Group’s Amgen AMGN Stock Holding History

Stanford Investment Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-324
Closed -$47K – 9
2016
Q4 		$47K Hold
324
– – 0.02% 146
2016
Q3 		$54K Hold
324
– – 0.03% 145
2016
Q2 		$49K Hold
324
– – 0.03% 143
2016
Q1 		$49K Hold
324
– – 0.03% 140
2015
Q4 		$53K Sell
324
-56
-15% -$8.8K 0.03% 125
2015
Q3 		$53K Hold
380
– – 0.04% 119
2015
Q2 		$58K Hold
380
– – 0.04% 118
2015
Q1 		$61K Hold
380
– – 0.05% 119
2014
Q4 		$61K Buy
+380
New +$59.2K 0.05% 122

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stanford Investment Group's AMGN Position: Q1 2017 in Review

Stanford Investment Group sold out of Amgen (AMGN) in Q1 2017, closing a stake of 324 shares — an estimated $47K sold.

Stanford Investment Group first reported a position in AMGN in Q4 2014 and held it in 9 quarters. The position peaked at $61K in Q1 2015. 1,601 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Stanford Investment Group reported no remaining Amgen position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 324 Amgen shares in Q1 2017, an estimated $47K.
  • Stanford Investment Group first reported a position in Amgen in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Amgen position peaked at $61K in Q1 2015.
  • 1,601 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.